Search by Drug Name or NDC
NDC 23155-0523-41 Prochlorperazine Edisylate 5 mg/mL Details
Prochlorperazine Edisylate 5 mg/mL
Prochlorperazine Edisylate is a INTRAMUSCULAR; INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.. The primary component is PROCHLORPERAZINE EDISYLATE.
Product Information
| NDC | 23155-0523 |
|---|---|
| Product ID | 23155-523_4a8ee5b4-7c34-4148-8172-56b4f07798c8 |
| Associated GPIs | 59200055202010 |
| GCN Sequence Number | 067700 |
| GCN Sequence Number Description | prochlorperazine edisylate VIAL 10 MG/2 ML INJECTION |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 30314 |
| HICL Sequence Number | 001628 |
| HICL Sequence Number Description | PROCHLORPERAZINE EDISYLATE |
| Brand/Generic | Generic |
| Proprietary Name | Prochlorperazine Edisylate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Prochlorperazine Edisylate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAMUSCULAR; INTRAVENOUS |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/mL |
| Substance Name | PROCHLORPERAZINE EDISYLATE |
| Labeler Name | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. |
| Pharmaceutical Class | Phenothiazine [EPC], Phenothiazines [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA204147 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 23155-0523-41 (23155052341)
| NDC Package Code | 23155-523-41 |
|---|---|
| Billing NDC | 23155052341 |
| Package | 10 VIAL in 1 PACKAGE (23155-523-41) / 2 mL in 1 VIAL (23155-523-31) |
| Marketing Start Date | 2015-06-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |